|
|
| |
| |
|
| | (a) | it is not reasonably possible for the person responsible |
|
| | under the licence (“R”) to identify the person falling within |
|
| | sub-paragraph (1)(b) (“P”), and |
|
225 | | (b) | where any information that relates to P (without identifying |
|
| | P or enabling P to be identified) is available to R, that |
|
| | information does not suggest that P would have objected to |
|
| | the use of P’s human cells to bring about the creation in |
|
| | vitro of an embryo or human admixed embryo for use for |
|
230 | | the purposes of the project. |
|
| | |
| | (a) | the person responsible under the licence (“R”) has taken all |
|
| | reasonable steps to contact the person falling within sub- |
|
| | paragraph (1)(b) (“P”) but has been unable to do so, |
|
235 | | (b) | R does not have any reason to believe P to have died, and |
|
| | (c) | the information relating to P that is available to R does not |
|
| | suggest that P would have objected to the use of P’s human |
|
| | cells to bring about the creation in vitro of an embryo or |
|
| | human admixed embryo for use for the purposes of the |
|
240 | | |
| | |
| | (a) | the person falling within sub-paragraph (1)(b) (“P”) has |
|
| | died since P’s human cells were first stored, |
|
| | (b) | the information relating to P that is available to the person |
|
245 | | responsible under the licence (“R”) does not suggest that P |
|
| | would have objected to the use of P’s human cells to bring |
|
| | about the creation in vitro of an embryo or human admixed |
|
| | embryo for use for the purposes of the project, and |
|
| | (c) | a person who stood in a qualifying relationship to P |
|
250 | | immediately before P died has given consent in writing to |
|
| | the use of P’s human cells to bring about the creation in |
|
| | vitro of an embryo or human admixed embryo for use for |
|
| | the purposes of the project. |
|
| | (5) | The HTA consent provisions apply in relation to consent for the |
|
255 | | purposes of sub-paragraph (4)(c) as they apply in relation to consent |
|
| | for the purposes of section 3(6)(c) of the Human Tissue Act 2004; |
|
| | and for the purposes of this sub-paragraph the HTA consent |
|
| | provisions are to be treated as if they extended to Scotland. |
|
| | (6) | In sub-paragraph (5) “the HTA consent provisions” means |
|
260 | | subsections (4), (5), (6), (7) and (8)(a) and (b) of section 27 of the |
|
| | |
| | (7) | In this paragraph references to the person responsible under the |
|
| | licence are to be read, in a case where an application for a licence is |
|
| | being made, as references to the person who is to be the person |
|
265 | | |
| | (8) | Paragraphs 1 to 4 of this Schedule do not apply in relation to a |
|
| | consent given for the purposes of sub-paragraph (4)(c).”’. |
|
|
|
| |
| |
|
| | As Amendments to Dawn Primarolo’s proposed Amendment (No. 102):— |
|
| |
| | |
| Line 206, leave out ‘to a significant extent’. |
|
| |
| | |
| Line 235, leave out ‘have any reason to believe’ and insert ‘know’. |
|
| |
| |
| | |
| Schedule 3, page 66, line 5, at end add— |
|
| | ‘13A | After paragraph 15 (as inserted by paragraph 13 above) insert— |
|
| | “Cases where consent not required for storage and research |
|
| | 15A | The human cells of a person (‘the donor’) may be used to bring |
|
| | about the creation of an embryo or a human admixed embryo in |
|
| | vitro; and any embryo or human admixed embryo so created may |
|
| | be used or stored for the purposes of any project of research without |
|
| | the donor’s consent if the following conditions are met: |
|
| | (a) | Condition A is that the human cells are lawfully taken from |
|
| | or provided by the donor; |
|
| | (b) | Condition B is that the human cells were first stored or used |
|
| | prior to the day on which Schedule 3 to the Human |
|
| | Fertilisation and Embryology Act 2008 comes into force; |
|
| | (c) | Condition C is that the human cells, embryos or human |
|
| | admixed embryos are used in circumstances such that the |
|
| | person carrying out the research (‘the researcher’) is not in |
|
| | possession, and not likely to come into possession, of |
|
| | information from which the donor can be identified; |
|
| | (d) | Condition D is that it is not reasonably possible to contact |
|
| | the donor to obtain their consent; |
|
| | (e) | Condition E is that there are reasonable grounds for |
|
| | believing that research of comparable effectiveness cannot |
|
| | be carried out if the project of research for which the human |
|
| | cells, embryos or human admixed embryos are stored or |
|
| | used has to be confined to, or related only to, material in |
|
| | relation to which there is an effective consent; and |
|
| | (f) | Condition F is that it does not appear to the researcher that |
|
| | the donor has indicated any objection to such use or storage |
|
| | |
| |
| | |
| Schedule 3, page 66, line 31, at end insert— |
|
| | ‘(5) | References in this Schedule to parental responsibility are— |
|
| | (a) | in relation to England and Wales, to be read in accordance with the |
|
| | |
| | (b) | in relation to Northern Ireland, to be read in accordance with the |
|
| | Children (Northern Ireland) Order 1995, and |
|
|
|
| |
| |
|
| | (c) | in relation to Scotland, to be read as references to parental |
|
| | responsibilities and parental rights within the meaning of the Children |
|
| | |
| | (6) | References in this Schedule to capacity are, in relation to England and Wales, |
|
| | to be read in accordance with the Mental Capacity Act 2005. |
|
| | (7) | References in this Schedule to the age of 18 years are, in relation to Scotland, |
|
| | to be read as references to the age of 16 years.’. |
|
| |
| |
| | |
| Schedule 4, page 67, line 8, after ‘gametes’, insert ‘including the mitochondria,’. |
|
| |
| |
| |
| | |
| Clause 15, page 11, line 47, leave out ‘ten’ and insert ‘seven’. |
|
| |
| | |
| Clause 15, page 12, line 3, leave out ‘ten’ and insert ‘seven’. |
|
| |
| |
| | |
| Clause 16, page 12, line 14, at end insert— |
|
| | ‘( ) | in paragraph (c), after “application” insert “or a licence under paragraph |
|
| | 3 of that Schedule authorising activities in connection with the derivation |
|
| | from embryos of stem cells that are intended for human application”, ’. |
|
| |
| | |
| Clause 16, page 12, line 15, after ‘(ca)’ insert ‘— (i)’. |
|
| |
| | |
| Clause 16, page 12, line 16, at end insert— |
|
| | ‘(ii) | after “that Schedule” insert “authorising activities otherwise than |
|
| | in connection with the derivation from embryos of stem cells that |
|
| | are intended for human application”, and’. |
|
| |
|
|
| |
| |
|
| |
| | |
| Clause 17, page 12, line 23, at end insert— |
|
| | ‘(1A) | In subsection (1)(b) for “equipment is” substitute “equipment and premises are”’. |
|
| |
| |
| | |
| Clause 18, page 13, line 29, after ‘person’, insert ‘and is so qualified by training |
|
| |
| |
| |
| | |
| Clause 19, page 15, line 12, leave out subsection (7). |
|
| |
| | |
| Clause 19, page 15, line 14, at end insert— |
|
| | ‘(8) | Notification to the applicant of a decision whether to grant or refuse a licence |
|
| | must be given within a specified time period to be determined by regulation.’. |
|
| |
| |
| | |
| Clause 20, page 15, line 38, at end insert— |
|
| | ‘(2A) | No more than four consecutive suspensions under subsection (1) can be granted, |
|
| | totalling a maximum period of twelve months.’. |
|
| |
| | |
| Clause 20, page 16, line 4, at end insert— |
|
| | ‘(6) | During a period of suspension all necessary, suitable and appropriate steps must |
|
| | be taken by the Authority to ensure there is no damage to the cells, embryos and |
|
| | gametes that were the responsibility of the licence holder or person responsible |
|
| | when the licence was suspended.’. |
|
| |
| |
| | |
| Clause 21, page 17, line 2, leave out from ‘wholly’ to ‘and’ in line 3 and insert ‘of |
|
| persons who were not members of the initial grant, revocation or variation committee.’. |
|
|
|
| |
| |
|
| |
| | |
| Clause 21, page 17, line 32, at end insert ‘within 28 days of the appeals committee |
|
| |
| |
| |
| |
| | |
| Clause 22, page 18, line 15, at end insert— |
|
| | ‘(3A) | After subsection (4) insert— |
|
| | “(4A) | In default of the exercise of the Authority of its power to make a direction |
|
| | under this section, a judge of the High Court may give permission for |
|
| | gametes stored under Schedule (3)(1)(2A) of this Act to be used within |
|
| | the UK or exported and used outside the United Kingdom.”.’. |
|
| |
| |
| |
| | |
| Clause 24, page 20, line 10, at end insert— |
|
| | ‘(5) | A relevant individual can also be an individual who has reached the age of 18 |
|
| | whose genetic parent was a relevant individual under subsection (4) but did not |
|
| | themselves consult the register and is themselves deceased.’. |
|
| |
| | |
| Clause 24, page 22, line 17, at end insert— |
|
| | ‘(c) | the donor has been given suitable opportunity to receive proper |
|
| | counselling about the implications of such a request having been made.’. |
|
| |
| | |
| Clause 24, page 23, line 7, leave out ‘any of’. |
|
| |
| | |
| Clause 24, page 23, line 42, at end insert— |
|
| | ‘(10) | In this section “reasonable period” means a period of no longer than 3 months’. |
|
| |
| |
| | |
| Clause 25, page 26, line 4, at end insert— |
|
| | ‘(za) | the disclosure is made— |
|
|
|
| |
| |
|
| | (i) | on clinical grounds, as part of the patient’s medical care, to a |
|
| | practitioner who is bound by the ordinary duty of patient |
|
| | |
| | (ii) | in order to ensure the safety of medical treatment which the |
|
| | patient is to receive outside of licensed premises.’. |
|
| |
| | |
| Clause 25, page 26, leave out lines 22 to 41 and insert— |
|
| | ‘(g) | the disclosure is made so that no individual can be identified from the |
|
| | |
| | (h) | the disclosure is of information other than identifying donor information |
|
| | and is made with the consent required by section 33AB,’. |
|
| |
| | |
| Clause 25, page 26, line 41, at end insert— |
|
| | |
| | (i) | is made by a person who is satisfied that it is necessary to make |
|
| | the disclosure to avert an imminent danger to the health of an |
|
| | |
| | (ii) | is of information falling within section 31(2)(a) which could be |
|
| | disclosed by virtue of paragraph (h) with P’s consent or could be |
|
| | disclosed to P by virtue of subsection (10), and |
|
| | (iii) | is made in circumstances where it is not reasonably practicable |
|
| | |
| |
| | |
| Clause 25, page 27, line 27, at end insert— |
|
| | ‘(v) | the disclosure is made in order to ensure the safety of medical treatment |
|
| | which the patient is to receive outside of licensed premises.’. |
|
| |
| | |
| Clause 25, page 27, line 27, at end insert— |
|
| | ‘(v) | the disclosure is made, on clinical grounds, as part of the patient’s |
|
| | medical care, to a practitioner who is bound by the ordinary duty of |
|
| | patient confidentiality.’. |
|
| |
| | |
| Clause 25, page 27, leave out lines 38 to 50. |
|
| |
| | |
| Clause 25, page 28, leave out lines 1 and 2. |
|
| |
| | |
| Clause 25, page 28, line 7, leave out from ‘of’ to ‘or’ in line 12 and insert |
|
| ‘identifying donor information,’. |
|
|
|
| |
| |
|
| |
| | |
| Clause 25, page 28, leave out lines 18 to 30. |
|
| |
| | |
| Clause 25, page 28, line 36, leave out ‘treated together with another’ and insert |
|
| ‘who is treated together with, or gives a notice under section 37 or 44 of the Human |
|
| Fertilisation and Embryology Act 2008 in respect of, another’. |
|
| |
| | |
| Clause 25, page 28, leave out lines 39 and 40. |
|
| |
| | |
| Clause 25, page 28, line 45, at end insert— |
|
| | ‘( ) | In this section “identifying donor information” means information enabling a |
|
| | person to be identified as a person whose gametes were used in accordance with |
|
| | consent given under paragraph 5 of Schedule 3 for the purposes of treatment |
|
| | services or non-medical fertility services in consequence of which an identifiable |
|
| | individual was, or may have been, born.’. |
|
| |
| | |
| Clause 25, page 28, line 45, at end insert— |
|
| | ‘33AB | Consent required to authorise certain disclosures |
|
| | (1) | This section has effect for the purposes of section 33A(2)(h). |
|
| | (2) | Subject to subsection (5), the consent required by this section is the |
|
| | consent of each individual who can be identified from the information. |
|
| | (3) | Consent in respect of a person who has not attained the age of 18 years |
|
| | |
| | (a) | by C, in a case where C is competent to deal with the issue of |
|
| | |
| | (b) | by a person having parental responsibility for C, in any other |
|
| | |
| | (4) | Consent to disclosure given at the request of another shall be disregarded |
|
| | unless, before it is given, the person requesting it takes reasonable steps |
|
| | to explain to the individual from whom it is requested the implications of |
|
| | compliance with the request. |
|
| | (5) | In the case of information which shows that any identifiable individual |
|
| | (“A”) was, or may have been, born in consequence of treatment services, |
|
| | the consent required by this section does not include A’s consent if the |
|
| | disclosure is necessarily incidental to the disclosure of information |
|
| | falling within section 31(2)(a). |
|
| | (6) | The reference in subsection (3) to parental responsibility is— |
|
| | (a) | in relation to England and Wales, to be read in accordance with |
|
| | |
|